Meeting
Abstract Number: 133
SHM Converge 2023
Background: Statin use has been shown to be beneficial in secondary stroke prevention. However, the optimal LDL level that should be achieved is still uncertain. Since there is a dearth of information, it is unclear if statins are useful in patients with stroke with baseline LDL ≤70 mg/dl in terms of morbidity and mortality outcomes. […]